Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Evofem BiosciencesXenon PharmaceuticalsAeglea Bio TherapeuticsForty SevenFulcrum Therapeutics
SymbolNASDAQ:EVFMNASDAQ:XENENASDAQ:AGLENASDAQ:FTSVNASDAQ:FULC
Price Information
Current Price$5.25$9.40$8.66$7.63$8.67
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$9.6667$21.50$17.00$25.5714$24.00
% Upside from Price Target84.13% upside128.72% upside96.30% upside235.14% upside176.82% upside
Trade Information
Market Cap$261.90 million$237.90 million$246.68 million$316.19 million$199.56 million
Beta0.621.331.091.91N/A
Average Volume26,01433,88657,021109,03052,515
Sales & Book Value
Annual RevenueN/A$310,000.00$3.89 millionN/AN/A
Price / SalesN/A781.4164.32N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.90) per share$3.79 per share$2.81 per share$4.29 per shareN/A
Price / BookN/A2.483.08N/AN/A
Profitability
Net Income$-125,710,000.00$-34,500,000.00$-44,350,000.00$-70,370,000.00$-32,590,000.00
EPS($5.74)($1.33)($2.13)($3.75)N/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/A-42.79%-71.47%-70.48%N/A
Return on Assets (ROA)-310.69%-32.04%-62.78%-61.40%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.18%0.05%N/AN/A
Current Ratio2.84%11.07%8.44%4.96%8.10%
Quick Ratio2.84%11.07%8.44%4.96%8.10%
Ownership Information
Institutional Ownership Percentage62.54%68.20%69.35%36.17%N/A
Insider Ownership Percentage13.40%8.35%12.60%37.40%N/A
Miscellaneous
Employees3089615762
Shares Outstanding46.60 million25.77 million28.89 million42.22 million23.34 million
Next Earnings Date11/6/2019 (Estimated)11/5/2019 (Estimated)11/14/2019 (Estimated)11/12/2019 (Estimated)11/25/2019 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable
 Evofem BiosciencesXenon PharmaceuticalsAeglea Bio TherapeuticsForty SevenFulcrum Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel